Jon Najarian says the size of bets against the market have been growing exponentially

Jon Najarian says the size of bets against the market have been growing exponentially

Jon Najarian, Co-Founder of MarketRebellion.com, joins Worldwide Exchange to discuss bets against the market, a stoppage and bounce for the S&P 500, and a bearish view for small caps.

Read More »
Inflation is likely to remain persistent, says Hightower's Stephanie Link

Inflation is likely to remain persistent, says Hightower’s Stephanie Link

Stephanie Link, chief investment strategist at Hightower Advisors, and Kathy Bostjancic, chief U.S. financial economist at Oxford Economics, join CNBC’s ‘Squawk Box’ to break down their expectations for inflation.

Read More »
Marcelo Ortega: 64% of to-be-installed solar panels are going to be delayed or cancelled

Marcelo Ortega: 64% of to-be-installed solar panels are going to be delayed or cancelled

Marcelo Ortega, a Renewable Energy Analyst at Rystad Energy, joins Worldwide Exchange to discuss the threats to U.S. renewable energy plans due to ongoing investigations and tariff impositions.

Read More »
Brian Sullivan's RBI: Record U.S. oil output is on the horizon according to the EIA

Brian Sullivan’s RBI: Record U.S. oil output is on the horizon according to the EIA

In Brian Sullivan’s daily RBI segment on Worldwide Exchange, he discusses a new EIA report that says 2023 will see record U.S. oil output and increases in natural gas prices, solar and wind, and coal production.

Read More »
CNBC TechCheck chats with Dapper Labs CEO — 5/10/22

CNBC TechCheck chats with Dapper Labs CEO — 5/10/22

Join CNBC TechCheck’s Julia Boorstin for a conversation with Dapper Labs CEO, Roham Gharegozlou, about the future of NFTs, blockchain & Web3. » Subscribe to CNBC TV: » Subscribe to CNBC: Turn to CNBC TV for the latest stock market…

Read More »
Biohaven Pharmaceuticals shares surge after Pfizer agrees to acquire company

Biohaven Pharmaceuticals shares surge after Pfizer agrees to acquire company

CNBC’s Jim Cramer and the ‘Squawk on the Street’ team break down shares of Biohaven Pharmaceuticals after drug giant Pfizer agreed to acquire the company for $11.6 billion.

Read More »
Opening Bell, May 10, 2022

Opening Bell, May 10, 2022

Watch the opening bell for the Nasdaq and the New York Stock Exchange from May 10, 2022.

Read More »
We see a lot of opportunities in the market today, says NZS' Slingerlend

We see a lot of opportunities in the market today, says NZS’ Slingerlend

Brad Slingerlend, NZS Capital, and Aaron Kessler, Raymond James, join ‘Squawk on the Street’ to discuss Kessler’s takeaway from Peloton’s earnings results this morning, the broader sell-off and more.

Read More »